ANTI-CD5 ANTIBODIES Provided is an antibody composition comprising at least two recombinant anti-CD5 antibodies capable of binding distinct, non-overlapping CD5 epitopes, wherein the antibody composition is capable of causing internalization of CD5 and comprises specified heavy and light chain CDRs. Further provided is the use of the compositions for treatment or prevention of cancer of rheumatoid arthritis.